These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 23301082)
1. Inhibition of sphingosine kinase-2 in a murine model of lupus nephritis. Snider AJ; Ruiz P; Obeid LM; Oates JC PLoS One; 2013; 8(1):e53521. PubMed ID: 23301082 [TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts. Beljanski V; Lewis CS; Smith CD Cancer Biol Ther; 2011 Mar; 11(5):524-34. PubMed ID: 21258214 [TBL] [Abstract][Full Text] [Related]
3. A novel sphingosine kinase inhibitor induces autophagy in tumor cells. Beljanski V; Knaak C; Smith CD J Pharmacol Exp Ther; 2010 May; 333(2):454-64. PubMed ID: 20179157 [TBL] [Abstract][Full Text] [Related]
4. Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. French KJ; Zhuang Y; Maines LW; Gao P; Wang W; Beljanski V; Upson JJ; Green CL; Keller SN; Smith CD J Pharmacol Exp Ther; 2010 Apr; 333(1):129-39. PubMed ID: 20061445 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo roles of sphingosine kinase 2 during dengue virus infection. Al-Shujairi WH; Clarke JN; Davies LT; Pitman MR; Calvert JK; Aloia AL; Pitson SM; Carr JM J Gen Virol; 2019 Apr; 100(4):629-641. PubMed ID: 30869582 [TBL] [Abstract][Full Text] [Related]
6. Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells. McNaughton M; Pitman M; Pitson SM; Pyne NJ; Pyne S Oncotarget; 2016 Mar; 7(13):16663-75. PubMed ID: 26934645 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats. Liu Q; Rehman H; Shi Y; Krishnasamy Y; Lemasters JJ; Smith CD; Zhong Z PLoS One; 2012; 7(7):e41834. PubMed ID: 22848628 [TBL] [Abstract][Full Text] [Related]
8. Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion. Shi Y; Rehman H; Ramshesh VK; Schwartz J; Liu Q; Krishnasamy Y; Zhang X; Lemasters JJ; Smith CD; Zhong Z J Hepatol; 2012 Jan; 56(1):137-45. PubMed ID: 21756852 [TBL] [Abstract][Full Text] [Related]
9. Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R(-/-)) mice. Poti F; Bot M; Costa S; Bergonzini V; Maines L; Varga G; Freise H; Robenek H; Simoni M; Nofer JR Thromb Haemost; 2012 Mar; 107(3):552-61. PubMed ID: 22234485 [TBL] [Abstract][Full Text] [Related]
10. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases. Gao P; Peterson YK; Smith RA; Smith CD PLoS One; 2012; 7(9):e44543. PubMed ID: 22970244 [TBL] [Abstract][Full Text] [Related]
11. A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes. Shin SH; Kim HY; Yoon HS; Park WJ; Adams DR; Pyne NJ; Pyne S; Park JW Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171607 [TBL] [Abstract][Full Text] [Related]
12. Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation. Snider AJ; Orr Gandy KA; Obeid LM Biochimie; 2010 Jun; 92(6):707-15. PubMed ID: 20156522 [TBL] [Abstract][Full Text] [Related]
13. Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640. White MD; Chan L; Antoon JW; Beckman BS Anticancer Res; 2013 Sep; 33(9):3573-9. PubMed ID: 24023282 [TBL] [Abstract][Full Text] [Related]
14. Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase. Chumanevich AA; Poudyal D; Cui X; Davis T; Wood PA; Smith CD; Hofseth LJ Carcinogenesis; 2010 Oct; 31(10):1787-93. PubMed ID: 20688834 [TBL] [Abstract][Full Text] [Related]
15. Sphingosine kinase 2 inhibitor ABC294640 suppresses neuronal excitability and inhibits multiple endogenously and exogenously expressed voltage-gated ion channels in cultured cells. Zhang F; Hu W; Qu L; Cang C Channels (Austin); 2020 Dec; 14(1):216-230. PubMed ID: 32615066 [TBL] [Abstract][Full Text] [Related]
16. Combined anticancer effects of sphingosine kinase inhibitors and sorafenib. Beljanski V; Knaak C; Zhuang Y; Smith CD Invest New Drugs; 2011 Dec; 29(6):1132-42. PubMed ID: 20473784 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression. Schrecengost RS; Keller SN; Schiewer MJ; Knudsen KE; Smith CD Mol Cancer Res; 2015 Dec; 13(12):1591-601. PubMed ID: 26271487 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma. Venkata JK; An N; Stuart R; Costa LJ; Cai H; Coker W; Song JH; Gibbs K; Matson T; Garrett-Mayer E; Wan Z; Ogretmen B; Smith C; Kang Y Blood; 2014 Sep; 124(12):1915-25. PubMed ID: 25122609 [TBL] [Abstract][Full Text] [Related]
19. The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein. Grbčić P; Eichmann TO; Kraljević Pavelić S; Sedić M Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639107 [TBL] [Abstract][Full Text] [Related]
20. Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation. Pyne NJ; McNaughton M; Boomkamp S; MacRitchie N; Evangelisti C; Martelli AM; Jiang HR; Ubhi S; Pyne S Adv Biol Regul; 2016 Jan; 60():151-159. PubMed ID: 26429117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]